Evaluation of SP14019-F-01 Topical Solution for the Treatment of Atopic Dermatitis. Pilot Study (CYCLATOP STUDY)
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Atopic dermatitis
- Focus Proof of concept; Therapeutic Use
- Acronyms CYCLATOP
- Sponsors Spherium Biomed
- 17 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 17 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 11 Oct 2016 Status changed from not yet recruiting to recruiting.